Navigation Links
Watson Pharmaceuticals Reports Second Quarter 2009 GAAP EPS of $0.46; Adjusted EPS $0.61; Company Raises 2009 Outlook
Date:7/29/2009

n effect until midnight Eastern Daylight Time, August 14, 2009. To access the live webcast, go to Watson's Investor Relations Web site athttp://ir.watson.com.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women's Health and Nephrology/Medical.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement

Statements contained in this press release that refer to Watson's estimated or anticipated future results or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. For instance, any statements in this press release concerning prospects related to Watson's strategic initiatives, product introductions and anticipated financial performance are forward-looking statements. It is important to note that Watson's goals and expectations are not predictions of actual performance. Watson's performance, at times, will differ from its goals and expectations. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the inherent uncertainty associated with financial projections; the impact of competitive products and pricing; the difficulty of predicting the timing or outcome of litigation; successful integration of strategic transactions; the ability to recognize the anticipated synergies and benefits of strategic transactions; variab
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Watson Announces License Agreement With GeneraMedix for Generic Version of Ferrlecit(R)
2. Watson CFO Mark W. Durand to Take Leave of Absence
3. Watson Confirms Filing of Abbreviated New Drug Application for Generic Sanctura XR(R)
4. Watson Pharmaceuticals Receives a Complete Response Letter for Its 24-Week Formulation of TRELSTAR(R) (triptorelin pamoate) NDA from US FDA
5. Watson to Host Second Quarter 2009 Earnings Conference Call and Webcast
6. Watson Pharmaceuticals Resumes Shipment of INFeD(R) (Iron Dextran Injection, USP)
7. Watson Pharmaceuticals Receives FDA Approval for Fruit and Cinnamon Flavored Coated Nicotine Gums
8. Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
9. Watson to Acquire Arrow Group
10. Watson Files FDA Application for Generic Mucinex(R) D
11. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Study after study has proven it true: exercise is ... Pennsylvania scientists suggests that exercise may have an added ... performed in a mouse model of melanoma, found that ... alone. , Joseph Libonati, an associate professor in ... of Innovative and Translational Nursing Research, was the senior ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 TayganPoint ... announced today that President and co-founder John Cassimatis ... Innovation Award Winners for 2014, recognizing the region’s ... as an emerging executive of the year. , ... and life sciences that continue to shape the ...
(Date:9/18/2014)... Ben Quirk, CEO of Quirk Healthcare ... Award by the Savannah Science Seminar in recognition for ... the nation and especially in Savannah. , “I am ... “The Savannah Science Seminar is an amazing program that ... have gone through the program,” he added. Eleventh graders ...
(Date:9/18/2014)... A group of international scientists have developed a new ... here . , The Wildlife Conservation Society (WCS)-led ... Tropical Diseases , describes the use of fecal samples ... have been exposed to the virus. This represents a ... can potentially change the way Ebola virus is studied ...
(Date:9/18/2014)... 18, 2014) The National Institutes of Health (NIH) ... four-year, $1.3 million grant to the Los Angeles Biomedical ... and development of a vaccine to protect patients from ... Staphylococcus aureus (MRSA). , The National Institute ... awarded the grant to LA BioMed infectious disease specialists ...
Breaking Medicine News(10 mins):Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2
... Bottom Line Results by Bringing Previously Unmanaged Areas of Spending ... N.C., June 18 SciQuest , Inc., ... Cincinnati Children,s Hospital Medical Center and ... are among the many well-known organizations that are radically reducing ...
... other warm weather ailments , , SAN ANTONIO, June 18 ... to help pet owners provide a lifetime of care for their ... aware this summer about the dangers of heat exposure. Pet emergency ... the summer months. Dogs and cats of all breeds are sensitive ...
... Practices as First Step in Cancer Care Reform , ... Davis (D-AL), Steve Israel (D-NY) and Mary Jo Kilroy (D-OH) ... Act of 2009. H.R. 2872 is a bill ... & Medicaid Services (CMS) to implement the Quality Cancer ...
... with 30% drop in hours spent together, report finds , ... parents are now spending more hours huddled alone around computer ... time families spend together. , That,s according to a new ... as group has fallen by nearly a third between 2005 ...
... a global leader in food safety and sanitation solutions, ... is safer to store, handle, and use than products ... formulated with generally recognized as safe (GRAS) ingredients, Chemstar ... Commitment(TM) to create products that are environmentally friendly. ...
... scientists are among a multinational collaborative group to have ... European Union. The research will focus on ... common to all solid tumours. Hypoxia causes a ... resistant to radiotherapy and most forms of chemotherapy; as ...
Cached Medicine News:Health News:Healthcare Organizations Rely on SciQuest To Optimize Supply Chains and Generate Savings 2Health News:Healthcare Organizations Rely on SciQuest To Optimize Supply Chains and Generate Savings 3Health News:Healthcare Organizations Rely on SciQuest To Optimize Supply Chains and Generate Savings 4Health News:Healthcare Organizations Rely on SciQuest To Optimize Supply Chains and Generate Savings 5Health News:Protect Your Pets During the Dog (and Cat) Days of Summer 2Health News:Protect Your Pets During the Dog (and Cat) Days of Summer 3Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 2Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 3Health News:House Bill to Provide Cancer Patients With Solution for Quality Cancer Care Within an Equitable Medicare Model 4Health News:Surging Internet Use Cutting Into Family Time 2Health News:Surging Internet Use Cutting Into Family Time 3Health News:$16.8 million study will breathe new life into cancer battle 2
(Date:9/18/2014)... , September 18, 2014 ... Markets ( http://www.researchandmarkets.com/research/f9nkkh/sugar_alcohols ) has announced the addition ... Business Report"  report to their offering.  ... analyzes the worldwide markets for Sugar Alcohols ... Segments: Food & Confectionery, Pharmaceuticals, Cosmetics, Oral-Care ...
(Date:9/18/2014)... , Sept. 18, 2014   MacPractice,s MacPractice ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  MacPractice MD MU version 5.0 was ... , an Office of the National Coordinator-Authorized Certification Body ...
(Date:9/18/2014)... Texas , Sept. 18, 2014  Casen Buswell has ... and muscles to harden.  His case is one of only ... the world.  The only hospital in the United ... the world, offering treatment with the dual wave-length laser, is ... San Antonio . Using a laser available in ...
Breaking Medicine Technology:Sugar Alcohols - Global Strategic Business Report 201 2Sugar Alcohols - Global Strategic Business Report 201 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2
Used to negotiate tortuous vessels....
BiodivYsio stent with biocompatible coating (phosphorylcholine)...
... The CYPHER Sirolimus-eluting Coronary Stent ... drug, called "sirolimus", a controlled-release ... delivery platform. Upon placement, sirolimus ... and impedes the process of ...
PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...
Medicine Products: